Bicycle Therapeutics PLC
NASDAQ:BCYC
Bicycle Therapeutics PLC
NASDAQ:BCYC
Price:
5.38
USD
2.87%
Market Cap:
$373.2m
Balance Sheet
Balance Sheet Decomposition
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
Balance Sheet Decomposition is not available for
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
Balance Sheet
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
9
|
68
|
63
|
92
|
136
|
439
|
339
|
526
|
880
|
|
| Cash |
9
|
68
|
63
|
92
|
136
|
439
|
339
|
526
|
880
|
|
| Total Receivables |
1
|
3
|
11
|
7
|
15
|
12
|
21
|
24
|
36
|
|
| Accounts Receivables |
0
|
0
|
5
|
0
|
6
|
1
|
2
|
0
|
0
|
|
| Other Receivables |
1
|
3
|
6
|
7
|
9
|
11
|
19
|
24
|
0
|
|
| Other Current Assets |
1
|
1
|
2
|
5
|
5
|
8
|
9
|
11
|
13
|
|
| Total Current Assets |
11
|
72
|
77
|
104
|
156
|
459
|
369
|
562
|
929
|
|
| PP&E Net |
1
|
1
|
2
|
4
|
4
|
18
|
33
|
28
|
17
|
|
| PP&E Gross |
1
|
1
|
2
|
4
|
4
|
18
|
33
|
28
|
17
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
4
|
5
|
8
|
13
|
19
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
2
|
2
|
3
|
9
|
6
|
11
|
|
| Total Assets |
12
N/A
|
74
+527%
|
82
+10%
|
110
+35%
|
161
+46%
|
480
+198%
|
411
-14%
|
595
+45%
|
957
+61%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
2
|
2
|
2
|
1
|
3
|
7
|
13
|
16
|
|
| Accrued Liabilities |
2
|
3
|
7
|
6
|
11
|
14
|
25
|
31
|
41
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
4
|
0
|
1
|
10
|
20
|
22
|
25
|
10
|
|
| Total Current Liabilities |
4
|
10
|
9
|
9
|
23
|
36
|
53
|
70
|
67
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
15
|
30
|
30
|
31
|
0
|
|
| Other Liabilities |
0
|
15
|
20
|
8
|
28
|
67
|
56
|
124
|
97
|
|
| Total Liabilities |
4
N/A
|
25
+550%
|
29
+19%
|
17
-42%
|
66
+286%
|
134
+103%
|
140
+5%
|
224
+61%
|
164
-27%
|
|
| Equity | ||||||||||
| Common Stock |
42
|
96
|
122
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Retained Earnings |
32
|
48
|
70
|
101
|
152
|
218
|
331
|
512
|
681
|
|
| Additional Paid In Capital |
0
|
1
|
2
|
195
|
250
|
568
|
601
|
883
|
1 473
|
|
| Other Equity |
2
|
0
|
2
|
2
|
3
|
3
|
0
|
1
|
0
|
|
| Total Equity |
8
N/A
|
49
+516%
|
52
+6%
|
93
+78%
|
96
+2%
|
346
+263%
|
271
-22%
|
371
+37%
|
793
+114%
|
|
| Total Liabilities & Equity |
12
N/A
|
74
+527%
|
82
+10%
|
110
+35%
|
161
+46%
|
480
+198%
|
411
-14%
|
595
+45%
|
957
+61%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
18
|
18
|
18
|
18
|
21
|
30
|
30
|
42
|
69
|
|
Switch to:
Switch to:
See Also
Discover More
